These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 799549)
1. Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure. Drayer DE Clin Pharmacokinet; 1976; 1(6):426-43. PubMed ID: 799549 [TBL] [Abstract][Full Text] [Related]
2. Active drug metabolites and renal failure. Drayer DE Am J Med; 1977 Apr; 62(4):486-9. PubMed ID: 851118 [TBL] [Abstract][Full Text] [Related]
3. Drug metabolism and active drug metabolites in renal failure. Reidenberg MM; Drayer DE J Dial; 1977; 1(4):313-8. PubMed ID: 608854 [No Abstract] [Full Text] [Related]
4. Impact of active metabolites on monitoring plasma concentrations of therapeutic drugs. Atkinson AJ; Stec GP; Lertora JJ; Ruo TI; Thenot JP Ther Drug Monit; 1980; 2(1):19-27. PubMed ID: 6762700 [TBL] [Abstract][Full Text] [Related]
5. Comparison of renal excretion of pethidine (meperidine) and its metabolites in old and young patients. Odar-Cederlöf I; Boréus LO; Bondesson U; Holmberg L; Heyner L Eur J Clin Pharmacol; 1985; 28(2):171-5. PubMed ID: 3987796 [TBL] [Abstract][Full Text] [Related]
6. Metabolites of cardiac antiarrhythmic drugs: their clinical role. Kates RE Ann N Y Acad Sci; 1984; 432():75-89. PubMed ID: 6441496 [TBL] [Abstract][Full Text] [Related]
7. Drug metabolites in renal failure: pharmacokinetic and clinical implications. Verbeeck RK; Branch RA; Wilkinson GR Clin Pharmacokinet; 1981; 6(5):329-45. PubMed ID: 7037261 [No Abstract] [Full Text] [Related]
8. Pharmacokinetics in patients with cardiac failure. Benowitz NL; Meister W Clin Pharmacokinet; 1976; 1(6):389-405. PubMed ID: 799548 [TBL] [Abstract][Full Text] [Related]
9. Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function. Drayer DE; Lowenthal DT; Woosley RL; Nies AS; Schwartz A; Reidenberg MM Clin Pharmacol Ther; 1977 Jul; 22(1):63-9. PubMed ID: 872496 [TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of N-acetylprocainamide. Connolly SJ; Kates RE Clin Pharmacokinet; 1982; 7(3):206-20. PubMed ID: 6178545 [TBL] [Abstract][Full Text] [Related]
11. Some consequences of drug choice and dosage regimen for patients with impaired kidney function. Vree TB; Hekster CA; van Dalen R Drug Intell Clin Pharm; 1983 Apr; 17(4):267-73. PubMed ID: 6839956 [TBL] [Abstract][Full Text] [Related]
12. Importance of metabolites in antiarrhythmic therapy. Woosley RL; Roden DM Am J Cardiol; 1983 Sep; 52(6):3C-7C. PubMed ID: 6194679 [TBL] [Abstract][Full Text] [Related]
13. Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide. Kim SY; Benowitz NL Drug Saf; 1990; 5(6):393-420. PubMed ID: 2285495 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure. Hoyer J; Schulte KL; Lenz T Clin Pharmacokinet; 1993 Mar; 24(3):230-54. PubMed ID: 8462229 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy. Obach RS Pharmacol Rev; 2013 Apr; 65(2):578-640. PubMed ID: 23406671 [TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics of procainamide. Karlsson E Clin Pharmacokinet; 1978; 3(2):97-107. PubMed ID: 346289 [TBL] [Abstract][Full Text] [Related]
17. Lethal accumulation of procainamide metabolite in severe renal insufficiency. Vlasses PH; Ferguson RK; Rocci ML; Raja RM; Porter RS; Greenspan AM Am J Nephrol; 1986; 6(2):112-6. PubMed ID: 2422935 [TBL] [Abstract][Full Text] [Related]